These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
99 related articles for article (PubMed ID: 27480296)
1. [Clinical features of patients with head and neck malignant tumor concurrent with multiple primary carcinoma]. Zhang XX; Yan F; Liu MB; Wang JL; Wu WM; Ma L; Huang DL Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2016 Jul; 51(7):491-6. PubMed ID: 27480296 [TBL] [Abstract][Full Text] [Related]
2. Synchronous and metachronous carcinomas of the esophagus and head and neck. Natsugoe S; Uchino Y; Kijima F; Shimada M; Shirao K; Kusano C; Baba M; Yoshinaka H; Fukumoto T; Mueller J; Stein HJ; Aikou T Dis Esophagus; 1997 Apr; 10(2):134-8. PubMed ID: 9179485 [TBL] [Abstract][Full Text] [Related]
3. [Clinical analysis of 71 cases of multiple primary cancers in head and neck squamous carcinomas]. Zhou YQ; Li XM; Gao CM; Zhao QL; Li GS; Cheng JM; Shang YD Zhonghua Er Bi Yan Hou Ke Za Zhi; 2004 Apr; 39(4):232-6. PubMed ID: 15283285 [TBL] [Abstract][Full Text] [Related]
4. Management of patients with head and neck tumours presenting at diagnosis with a synchronous second cancer at another anatomic site. Graff P; Schipman B; Desandes E; Mecellem H; Toussaint B; Cortese S; Marchal F; Kaminsky MC; Geoffrois L; Peiffert D Clin Oncol (R Coll Radiol); 2011 Apr; 23(3):174-81. PubMed ID: 21130631 [TBL] [Abstract][Full Text] [Related]
5. Outcomes for patients with synchronous and metachronous primary lung cancer after diagnosis of head and neck cancer. Tamjid B; Phan P; John T; Mitchell P; Gan H Head Neck; 2017 Aug; 39(8):1544-1549. PubMed ID: 28593651 [TBL] [Abstract][Full Text] [Related]
7. Synchronous and metachronous squamous cell carcinomas of the head and neck mucosal sites. Erkal HS; Mendenhall WM; Amdur RJ; Villaret DB; Stringer SP J Clin Oncol; 2001 Mar; 19(5):1358-62. PubMed ID: 11230479 [TBL] [Abstract][Full Text] [Related]
8. Multiple primary carcinomas with esophageal squamous cell cancer: clinicopathologic outcome. Natsugoe S; Matsumoto M; Okumura H; Ishigami S; Uenosono Y; Owaki T; Takao S; Aikou T World J Surg; 2005 Jan; 29(1):46-9. PubMed ID: 15592914 [TBL] [Abstract][Full Text] [Related]
9. Esophageal cancers with synchronous or antecedent head and neck cancers: a more formidable challenge? Lo OS; Law S; Wei WI; Ng WM; Wong KH; Tong KH; Wong J Ann Surg Oncol; 2008 Jun; 15(6):1750-6. PubMed ID: 18347873 [TBL] [Abstract][Full Text] [Related]
10. [Planned neck dissection in the treatment of locally advanced head and neck squamous cell carcinoma]. Jiang L; Lou JL; Wang KJ; Fang MY; Fu ZF Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2018 Feb; 53(2):92-96. PubMed ID: 29429177 [No Abstract] [Full Text] [Related]
11. Second primary lung cancers following a diagnosis of primary head and neck cancer. Griffioen GH; Louie AV; de Bree R; Smit EF; Paul MA; Slotman BJ; Leemans CR; Senan S Lung Cancer; 2015 Apr; 88(1):94-9. PubMed ID: 25662386 [TBL] [Abstract][Full Text] [Related]
12. Long-term results after esophagectomy for squamous cell carcinoma of the esophagus associated with head and neck cancer. Wind P; Roullet MH; Quinaux D; Laccoureye O; Brasnu D; Cugnenc PH Am J Surg; 1999 Sep; 178(3):251-5. PubMed ID: 10527449 [TBL] [Abstract][Full Text] [Related]
13. Radiotherapy potentiation with weekly cisplatin compared to standard every 3 weeks cisplatin chemotherapy for locoregionally advanced head and neck squamous cell carcinoma. Fayette J; Molin Y; Lavergne E; Montbarbon X; Racadot S; Poupart M; Ramade A; Zrounba P; Ceruse P; Pommier P Drug Des Devel Ther; 2015; 9():6203-10. PubMed ID: 26648696 [TBL] [Abstract][Full Text] [Related]
14. Association of multiple Lugol-voiding lesions with synchronous and metachronous esophageal squamous cell carcinoma in patients with head and neck cancer. Muto M; Hironaka S; Nakane M; Boku N; Ohtsu A; Yoshida S Gastrointest Endosc; 2002 Oct; 56(4):517-21. PubMed ID: 12297767 [TBL] [Abstract][Full Text] [Related]
15. Prognosis was not deteriorated by multiple primary cancers in esophageal cancer patients treated by radiotherapy. Shirai K; Tamaki Y; Kitamoto Y; Murata K; Satoh Y; Higuchi K; Ishikawa H; Nonaka T; Takahashi T; Nakano T J Radiat Res; 2013 Jul; 54(4):706-11. PubMed ID: 23381956 [TBL] [Abstract][Full Text] [Related]
17. Survival study and treatment strategy for second primary malignancies in patients with head and neck squamous cell carcinoma and nasopharyngeal carcinoma. Tsou YA; Hua CH; Tseng HC; Lin MH; Tsai MH Acta Otolaryngol; 2007 Jun; 127(6):651-7. PubMed ID: 17503236 [TBL] [Abstract][Full Text] [Related]
18. Neck dissection in the combined-modality therapy of patients with locoregionally advanced head and neck cancer. Argiris A; Stenson KM; Brockstein BE; Mittal BB; Pelzer H; Kies MS; Jayaram P; Portugal L; Wenig BL; Rosen FR; Haraf DJ; Vokes EE Head Neck; 2004 May; 26(5):447-55. PubMed ID: 15122662 [TBL] [Abstract][Full Text] [Related]
19. Treatment results for simultaneous primary squamous cell carcinomas of the head and neck. McCollough WM; Million RR; Parsons JT; Mendenhall WM; Cassisi NJ Laryngoscope; 1988 Jan; 98(1):79-82. PubMed ID: 3336266 [TBL] [Abstract][Full Text] [Related]
20. Clinicopathologic features of metachronous or synchronous gastric cancer patients with three or more primary sites. Kim JH; Rha SY; Kim C; Kim GM; Yoon SH; Kim KH; Kim MJ; Ahn JB; Chung HC; Roh JK; Kim HS Cancer Res Treat; 2010 Dec; 42(4):217-24. PubMed ID: 21253324 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]